Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are doing great.
Just acknowledging the lesson speaks loads about your prospects for profits in these small stocks. Rent them--don't buy them.
Good luck
Cheez--why ON GOD"S GREEN EARTH, have you not taken a ton of profits from .15 to .28 on the way up? I mean, really. Greed?
I know--50% to 100% gains should be enough for many. But it isn't for many in these small stocks, Noob.
KAC chart
I truly feel sorry for those that bought SPNG in the teens and thought they would see one dollar. I have been there before with other stocks.
Now I always take profits--even if it is only 50-100%. I have a friend that boasted to me that he first bought SPNG at .045 and I begged him take some profits where he had nothing at risk and 100% return in his pocket.---let the rest ride.
But, no....he saw $1.00 coming.
He sold 80% of what he owned at .10--because of me ragging on him.
GLTA....there may be a turn--but now untilthey publicly answer all these concerns.
GLGT chart
LDSR chart
Put a fork in the Sponge.... it is done.
It was too good to be true.
And it was not true.
Next news from the comapny should have a little in it about potential revenues for the next 12 months or so.
JMO
CHART
LGDI
MESA on the runway? Ready for takoff?
Sorry, EMGE chart
Charts on --- EMGE, UTRM, USEG, LGDI
EMGE
UTRM
USEG
LGDI
LGDI bouncing off the filling on that gap. All clear.
MESA chart
MESA, PTSC, and UTRM on watch
Love them boucnc plays
Well, here is half a UTRM chart--without annotations, Clay.
Thanks in advance
CHART Request, Clay--UTRM, coming off a bottom. Could you do one?
Thanks
Nice actionon PTSC today, PIE. Bounce off support and, now, if they could get some news out.
PTSC...sweet
CHART on ESRG, maddog, looks like it is holding in there. If they could get some news out on their proposal pipeline, we could get som real action, imo.
CHART on ESRG, maddog, looks like it is holding in there. If they could get some news out on their proposal pipeline, we could get som real action, imo.
There was some info on that Trade show, SLM, on a blog they have--- www.electronblog.com I asked my friend who went if the people were all residential types, and he said he overheard some basic tire kickers that were residential. But he heard a developer/landlord who was retrofitting a building of his with green technology to try for a LEED certification. A solar system was what he was asking about.
UTRM chart is shaping up for a move, IMO, balamidas
Could get to .18 easily if it breaks through .11--JMHO
I feel much better after their PR today.
Whew! I was worried for a few days.
WANG--watch this UTRM down here. It could be early, but...
lol
UTRM is acting good here, John. I agree, if they canget over .11---it runs
UTRM
ESLR chart--waiting
Soros owns 10% of LGDI. And institutions own 70% ofthe company.
At least, as of 12 Dec. 2008.
Renika Pty Ltd 21.22%
Atticus Capital LP 13.69%
Soros Fund Management
10.2%
IFFCO 8.84%
Chabad House of Caufield
8.8%
Park Avenue Discoveries LLC
4.79%
Parella Weinberg Partners 3.09%
Total 70.63%
*As at 12 December 2008
It would be nice if the company could give shareholders an idea of revenue potential...with all the caveats attached. Today's PR is written more for the industry insider, which is helpful, but investors could use more of a simplistic explanation, IMO.
Key point in today's news:
As reported on August 28, 2009, the Paradise South (previously Lady Annie) EPM 16942 exploration permit was granted. This has allowed Legend to begin clearances for drilling which will commence early October 2009 and is aimed at delineating an initial 20-30 million tonnes of reserves by the second quarter 2010 to support a 1 Mtpa beneficiation plant.
Like clockwork---Gap has been filled today
Thanks, John, for the congrats on IMDS. Nice consolidation
IMDS has awesome volume
IMDS chart --Up 175% so far
VCU Massey Cancer Center Clinical Study Examines Ability of a Medical Device to Decrease Pain in Cancer Patients
Richmond, Va. (July 2, 2009)–Virginia Commonwealth University Massey Cancer Center opened a Phase II clinical study to see whether an FDA-cleared pain therapy device helps decrease pain in cancer patients.
The study will examine the device’s effect on pain associated with chemotherapy-induced peripheral neuropathy (CIPN), which can produce sharp pains in the hands and feet of cancer patients who are undergoing chemotherapy. This debilitating pain affects about 20 to 30 percent of cancer patients.
The pain therapy device is exclusively licensed by Competitive Technologies, Inc. of Fairfield, Conn.
“Exploring ways to treat pain other than prescribing opioids such as morphine is key to our mission of improving quality of life for cancer patients,” said Thomas J. Smith, MD, a principal investigator on the study. Smith is an international leader in palliative care and pain management, along with co-investigator Patrick Coyne, R.N., M.S.N.
Massey is the first site in the U.S. to offer a clinical study for pain in cancer patients with this device. The treatment protocol calls for 15 patients with CIPN to be studied first.
Cancer patients interested in learning more abut the study may contact clinical research nurse Patricia Dodson, RN, pdodson@mcvh-vcu.edu or 804-828-5242.
About the Device
The medical device is a noninvasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs.
Using a biophysical rather than a biochemical approach, the unit has a multi-processor that’s able to simultaneously treat multiple pain areas by applying surface electrodes to the skin.
The device has been used on more than 3,000 patients in Europe, including at the Pain Management Center at Tor-Vergata University Medical Center in Rome It was developed by Prof. Guiseppe Marinero, an Italian bioengineer and medical doctor. It is also being studied at other academic medical centers in the U.S. for pain related to other medical conditions besides cancer.
# # #
About Massey Cancer Center
The VCU Massey Cancer Center is one of 65 National Cancer Institute-designated institutions that leads and shapes America’s cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. It offers more clinical trials than any other cancer center in Virginia, many of which are based on findings from its 175 faculty research members.
In addition, Massey is one of only six national centers designated by the Robert Woods Johnson Foundation as a Palliative Care Leadership Center, through which Smith and colleagues train other professionals from across the country in how to develop and administer palliative care programs, which include pain and symptom management.
Visit Massey online at www.massey.vcu.edu.
FOR IMMEDIATE RELEASE
Contact: Andrea Butler
804-628-2111; albutler@vcu.edu
IMDS --boom!
IMDS up 150% on big news
Waiting for the GAP FILL AT .84
Chart on LGDI - on watch for pullback and reload